Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice

S. S. Lee, V. G. Bain, K. Peltekian, M. Krajden, E. M. Yoshida, M. Deschenes, J. Heathcote, R. J. Bailey, S. Simonyi, M. Sherman

Research output: Contribution to journalArticlepeer-review

75 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice'. Together they form a unique fingerprint.

Medicine & Life Sciences